FMP
NASDAQ
2 USD
-0.17 (-8.5%)
Dr. Lindsay Allan Rosenwald
Healthcare
Biotechnology
https://www.fortressbiotech.com
NASDAQ
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch symptoms; Ceracade for dry skin conditions; Luxamend for dressing and managing wounds; and Accutane capsules for severe recalcitrant nodular acne. It also develops late stage product candidates, such as intravenous Tramadol for the treatment of post-operative acute pain; CUTX-101, an injection for the treatment of Menkes disease; MB-107 and MB-207 for the ...
0001429260
US34960Q3074
34960Q109
1111 Kane Concourse
781 652 4500
US
187
Nov 17, 2011
0001429260
NASDAQ
Biotechnology
Healthcare
34960Q109
US34960Q3074
US
2
1.51
475.39k
36.75M
-
1.24-12.75
5.31
-
-
-
-
-0.18
-
https://www.fortressbiotech.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.